Overview

Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The study is designed to look at the effect of different bone treatment plans on bone loss after kidney or kidney/pancreas transplant.
Phase:
N/A
Details
Lead Sponsor:
University of Nebraska
Treatments:
Alendronate
Calcium
Calcium Carbonate
Calcium, Dietary
Diphosphonates
Ergocalciferols
Pancrelipase
Vitamin D
Vitamins
Zoledronic Acid